PIK4CA as modifier of the RAC pathway and methods of use

Details for Australian Patent Application No. 2005287169 (hide)

Owner Exelixis, Inc.

Inventors Bjerke, Lynn Margaret; Kadyk, Lisa C.; Heuer, Timothy S.; Francis, George Ross

Agent Davies Collison Cave

Pub. Number AU-A-2005287169

PCT Pub. Number WO2006/033942

Priority 60/611,127 17.09.04 US

Filing date 15 September 2005

Wipo publication date 30 March 2006

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

29 March 2007 PCT application entered the National Phase

  PCT publication WO2006/033942 Priority application(s): WO2006/033942

27 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005287170-Pyrazole kinase modulators and methods of use

2005287162-Perfusion bioreactor for culturing cells